Macrocyclic compounds as ALK, FAK and JAK2 inhibitors
US9487529B2 · kind B2 · utility
1Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2013 |
| Grant date | Nov 8, 2016 |
| Priority date | — |
| Expiry date | Jul 12, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula Ior a pharmaceutically acceptable salt forms thereof, wherein R1, R2, R3, R4, R5, A and X are as defined herein, methods of treatment and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.